S&P 500 7,609.78 +0.13% NASDAQ 27,093.90 +0.03% DOW 51,307.79 +0.45% R2K 2,931.96 +0.90% VIX 15.77 -1.74%
N
BDX Becton, Dickinson and Company NYQ
$144.43 -0.90 (-0.62%)
Pullback · -0.71σ

132-Day TAO Zones

21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Key statistics

Mkt cap $39.8B
P/E ttm 25.2
Fwd P/E 10.8
Beta 0.28
Day range $144.43
52w range $141.82 – $187.35
Avg vol 2.9M
RSI(2) 7.7
ROE 6.7%
Net mgn 5.1%
FCF mgn 20.4%
Debt/Eq 0.72
Div yld 289.00%
Sector Healthcare
Industry Medical Instruments & Supplies
Next earn 2026-08-06

Matrix setup grades

Long
score 17 · tech 17 / 80 · support 0 / 20
KC1 lower, -0.68 ATR from EMA21 · no notable pattern
  • · KC1 lower stretch — light dip
Short
score 15 · tech 15 / 80 · support 0 / 20
below KC1 upper, -0.68 ATR from EMA21 · no notable pattern
  • · Stochastic bear cross
  • · Aligned with weak downtrend

Options · swing

See more →
CALL $145 2026-07-17
$4.60
PUT $145 2026-07-17
$6.60

Insider activity

See more →

No Form 4 filings in the last 30 days.

Earnings

See more →
Last reported
2026-05-07
EPS (act / est)
2.90 / 2.77
Surprise
+4.5%
Next report
2026-08-06

About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and …